| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972833 | The Journal of Heart and Lung Transplantation | 2007 | 7 Pages |
Abstract
Sitaxsentan may represent a safe and efficacious alternative endothelin receptor antagonist for patients discontinuing bosentan.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Raymond L. MD, Sanjay MD, Anne MD, E. Clinton MD, Ronald J. MD, Robyn J. MD,